Gabelli Funds’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Gabelli Funds’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-271,810	Closed	-$6.55M	–	1207
2023 Q1	$6.55M	Buy	+271,810	New	+$3.41M	0.05%	402

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Gabelli Funds's PRVB Position: Q2 2023 in Review

Gabelli Funds sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 271,810 shares — an estimated $6.55M sold.

Gabelli Funds first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $6.55M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Gabelli Funds reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Gabelli Funds sold 271,810 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $6.55M.
Gabelli Funds first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Gabelli Funds's Provention Bio, Inc. Common Stock position peaked at $6.55M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Gabelli Funds's 13F filing for Q2 2023, filed 10 Aug 2023.